Home / XBRANE.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does XBRANE.ST make money? Does XBRANE.ST have pricing power? What's the Earnings Whisper? Will XBRANE.ST profit more as the business scales? What is XBRANE.ST's management track record? Is XBRANE.ST's current price justified?

Xbrane Biopharma AB (publ)

SEK 14.15 +$3.78 (+36.45%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 13.00

Day Range

SEK 13.70SEK 15.50

Year Range

SEK 5.42SEK 20.00

Market Cap

172.27M

AVG Volume

66.72K

Trailing/Forward PE

-7.83/-

PEG ratio

0.07

Dividend Yield

Next Earnings Date

2027-02-19

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · A

XBRANE.ST Revenue (SEK) by year
Period	Revenue (SEK)
2025	152.34M
2024	198.78M
2023	238.68M
2022	57.62M
2021	18.87M
2020	6.82M
2019	600K
2018	112.95M
2017	20.84M
2016	2.49M

Net Income (SEK) · A

XBRANE.ST Net Income (SEK) by year
Period	Net Income (SEK)
2025	127.24M
2024	-266.22M
2023	-388.14M
2022	-172.23M
2021	-188.38M
2020	-223.08M
2019	-166.04M
2018	-13.24M
2017	-47.77M
2016	-33.29M

Operating Income (SEK) · A

XBRANE.ST Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	-25.56M
2024	-222.06M
2023	-318.89M
2022	-166.22M
2021	-184.67M
2020	-222.31M
2019	-164.62M
2018	-11.42M
2017	-47.55M
2016	-33.15M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (SEK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 19 Feb 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Xbrane Biopharma AB (publ)

Earnings: XBRANE.ST

Video analysis: XBRANE.ST

News: XBRANE.ST

Similar companies